Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Mankind Pharmahas informed that it enclosed a copy of the certificate received from KFin Technologies, the Registrar and Share Transfer Agent of the Company for the quarter ended on June 30, 2026.
The above information is a part of company’s filings submitted to BSE.